Bone morphogenetic protein-2 (BMP-2) in the treatment of pyogenic vertebral osteomyelitis

Spine

Volumn 32, Issue 26, 2007, Pages 2996-3006

  Allen, R Todd ^a   Lee, Yu Po ^a   Stimson, Elizabeth ^a   Garfin, Steven R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BMP 2; Pyogenic; Spine fusion; Vertebral osteomyelitis

Indexed keywords

ANTIBIOTIC AGENT; BONE MORPHOGENETIC PROTEIN 2; C REACTIVE PROTEIN;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CERVICAL SPINE; CLINICAL ARTICLE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CONVALESCENCE; DISEASE MARKER; DISEASE PREDISPOSITION; EPIDURAL ABSCESS; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; FOLLOW UP; HUMAN; ILIAC CREST; LEUKOCYTE COUNT; LUMBAR SPINE; MALE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAPLEGIA; PERIOPERATIVE COMPLICATION; PRIORITY JOURNAL; QUADRIPLEGIA; RETROSPECTIVE STUDY; SPINE FUSION; SPONDYLITIS; STAPHYLOCOCCUS AUREUS; THORACIC SPINE; VERTEBRA BODY; VISUAL ANALOG SCALE; X RAY FILM;

ADULT; AGED; BONE MORPHOGENETIC PROTEINS; CERVICAL VERTEBRAE; FEMALE; HUMANS; LUMBAR VERTEBRAE; MALE; MIDDLE AGED; OSTEOMYELITIS; RETROSPECTIVE STUDIES; SPINAL FUSION; THORACIC VERTEBRAE; TRANSFORMING GROWTH FACTOR BETA; TREATMENT OUTCOME;

EID: 37349043206     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e31815cde3e     Document Type: Article

References (44)

1. Currier BL, Eismont FJ. Infections of the spine. In: Herkowitz HN, Garfin SR, Balderston RA, et al, eds. The Spine, vol. 2, 4th ed. Philadelphia: Saunders; 1999:1207-58.
2. Swanson AN, Pappou IP, Cammisa FP, et al. Chronic infections of the spine: surgical Indications and treatments. Clin Orthop 2006;444:100-6.
3. Nakase H, Tamaki R, Matsuda R, et al. Delayed reconstruction by titanium mesh-bone graft composite in pyogenic spinal infection: a long-term follow-up study. J Spinal Disord Tech 2006;19:48-54.
4. Fayazi AH, Ludwig SC, Dabbah M, et al. Preliminary results of staged anterior debridement and reconstruction using titanium mesh cages in the treatment of thoracolumbar vertebral osteomyelitis. Spine J 2004;4:388-95.
5. Korovessis P, Petsinis G, Koureas G, et al. Anterior surgery with insertion of titanium mesh cage and posterior instrumented fusion performed sequentially on the same day under one anesthesia for septic spondylitis of thoracolumbar spine: is the use of titanium mesh cages safe? Spine 2006;31:1014-9.
6. Burkus JK, Gornet MF, Dickman CA, et al. Anterior lumbar interbody fusion using rhBMP-2 with tapered interbody cages. J Spinal Disord Tech 2002;15:337-49.
7. Hee HT, Majd ME, Holt RT, et al. Better treatment of vertebral osteomyelitis using posterior stabilization and titanium mesh cages. J Spinal Disord Tech 2002;15:149-56.
8. Burkus JK, Sandhu HS, Gornet MF, et al. Use of rhBMP-2 in combination with structural cortical allografts: clinical and radiographic outcomes in anterior lumbar spinal surgery. J Bone Joint Surg Am 2005;87:1205-12.
9. Fitzpatrick DJ, Cafferkey MT, Toner M, et al. Osteomyelitis with methicillin-resistant Staphylococcus aureus. J Hosp Infect 1986;8:24-30.
10. Schuster JM, Avellino AM, Mann FA, et al. Use of structural allografts in spinal osteomyelitis: a review of 47 cases. J Neurosurg Spine 2000;93:8-14.
11. Ogden AT, Kaiser MG. Single-stage debridement and instrumentation for pyogenic spinal infections. Neurosurg Focus 2004;17:E5.
12. Govender S, Csimma C, Genant HK, et al. Recombinant human bone morphogenetic protein-2 for treatment of open tibial fractures: a prospective, controlled, randomized study of four hundred and fifty patients. J Bone Joint Surg Am 2002;84:2123-34.
13. Hadjipavlou AG, Mader JT, Necessary JT, et al. Hematogenous pyogenic spinal infections and their surgical management. Spine 2000;25:1668-79.
14. Medtronic Sofamor Danek USA, Inc., Infuse Package Insert, 2005.
15. Carragee EJ. Instrumentation of the infected and unstable spine: a review of 17 cases from the thoracic and lumbar spine with pyogenic infections. J Spinal Disord 1997;10:317-24.
16. McDonnell MF, Glassman SD, Dimar JR 2nd, et al. Perioperative complications of anterior procedures on the spine. J Bone Joint Surg Am 1996;78:839-47.
17. Urist MR. Bone: formation by autoinduction. Science 1965;150:893-9.
18. U.S. Food and Drug Administration, Department of Health and Human Services, Center for Devices and Radiological Health. InFUSE Bone Graft/LT-CAGE Lumbar Tapered Fusion Devices. P000058. July 2, 2002. www.fda.gov/cdrh/pdf/ P000058.html.
19. Burkus JK, Dorchak JD, Sanders DL. Radiographic assessment of interbody fusion using recombinant human bone morphogenetic protein type 2. Spine 2003;28:372-7.
20. Boden SD, Zdeblick TA, Sandhu HS, et al. The use of rhBMP-2 in interbody fusion cages. Definitive evidence of osteoinduction in humans: a preliminary report. Spine 2000;25:376-81.
21. Swiontkowski MF, Aro HT, Donell S, et al. Recombinant human bone morphogenetic protein-2 in open tibial fractures: a subgroup analysis of data combined from two prospective randomized studies. J Bone Joint Surg Am 2006;88:1258-65.
22. Chen X, Kidder LS, Lew WD. Osteogenic protein-1 induced bone formation in an infected segmental defect in the rat femur. J Orthop Res 2002;20:142-50.
23. Chen X, Schmidt AH, Tsukayama DT, et al. Recombinant human osteogenic protein-1 induces bone formation in a chronically infected, internally stabilized segmental defect in the rat femur. J Bone Joint Surg Am 2006;88:1510-23.
24. Nair SP, Meghji S, Wilson M, et al. Bacterially infected bone destruction: mechanisms and misconceptions. Infec Immun 1996;64:2371-80.
25. Donlan RM, Costerton JW. Biofilms: survival mechanisms of clinically relevant microorganisms. Clin Microbiol Rev 2002;15:167-93.
26. Pappou IP, Papadopoulos EC, Sama AA, et al. Postoperative infections in interbody fusion for degenerative spinal disease. Clin Orthop 2006;444:120-8.
27. Abbey DM, Turner DM, Warson JS, et al. Treatment of postoperative wound infections following spinal fusion with instrumentation. J Spinal Disord 1995;8:278-83.
28. Deyo RA, Cherkin DC, Loeser JD, et al. Morbidity and mortality in association with operations on the lumbar spine: the influence of age, diagnosis, and procedure. J Bone Joint Surg Am 1992;74:536-43.
29. Weinstein MA, McCabe JP, Cammisa FP Jr. Postoperative spinal wound infection: a review of 2,391 consecutive index procedures. J Spinal Disord 2000;13:422-6.
30. Carreon LY, Puno RM, Dimar JR Jr, et al. Perioperative complications of posterior lumbar decompression and arthrodesis in older adults. J Bone Joint Surg Am 2003;85:2089-92.
31. Larsson S, Thelander U, Friberg S. C-reactive protein (CRP) levels after elective orthopedic surgery. Clin Orthop 1992;275:237-42.
32. Dimar JR, Carreon LY, Glassman SD, et al. Treatment of pyogenic vertebral osteomyelitis with anterior debridement and fusion followed by delayed posterior spinal fusion. Spine 2004;29:326-32.
33. Hoffman GO, Bar T, Buhren V. The osteosynthesis implant and early postoperative infection: healing with or without removal of the material? Chirurg 1997;68:1175-80.
34. Przybylski GJ, Sharan AD. Single stage autogenous bone grafting and internal fixation in the surgical management of pyogenic discitis and vertebral osteomyelitis. J Neurosurg Spine 2001;94:1-7.
35. Fang D, Cheung KM, Dos Remedios ID, et al. Pyogenic vertebral osteomyelitis: treatment by anterior spinal debridement and fusion. J Spinal Disord 1994;7:173-80.
36. Dennis S, Watkins, Landaker S, et al. Comparison of disc space heights after anterior lumbar interbody fusion. Spine 1989;14:876-8.
37. Sasso RC, Kitchel SH, Dawson EG. A prospective, randomized controlled trial of anterior lumbar interbody fusion using a titanium cylindrical threaded fusion device. Spine 2004;29:113-22.
38. Sheehan E, McKenna J, Mulhall KJ, et al. Adhesion of Staphylococcus to orthopaedic metals, an in vivo study. J Orthop Res 2004;22:39-43.
39. Liljenqvist U, Lerner T, Bullmann V, et al. Titanium cages in the surgical treatment of severe vertebral osteomyelitis. Eur Spine J 2003;12:606-12.
40. Deckers MM, van Bezooijen RL, van der Horst G, et al. Bone morphogenetic proteins stimulate angiogenesis through osteoblast- derived vascular endothelial growth factor A. Endocrinology 2002;143:1545-53.
41. Carano RA, Filvaroff EH. Angiogenesis and bone repair. Drug Discov Today 2003;8:980-9.
42. Dorai H, Sampath TK. Bone morphogenetic protein-7 modulates genes that maintain the vascular smooth muscle cell phenotype in culture. J Bone Joint Surg Am 2001;83(suppl):70-8.
43. Langenfeld EM, Langenfeld J. Bone morphogenetic protein-2 stimulates angiogenesis in developing tumors. Mol Cancer Res 2004;2:141-9.
44. Muschler GF, Nakamoto C, Grauer JN. Bone healing and grafting (Basic Science). In: Vaccaro A, ed. Orthopaedic Knowledge Update 8. Rosemont, IL: American Academy of Orthopaedic Surgeons; 2005:29-37.